stockrowSo-Young International Inc. Sponsored ADR
SY Healthcare Health Information Services
So-Young International Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $217.8 million, up 8.41% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +40.0%
- Free cash flow
- −798.4%
- Total debt
- +99.7%
Quarter to June 2026, against a year earlier
Follow SY
Alert me
So-Young International Inc. Sponsored ADR (SY) EV/Sales
As of 5 November 2026, So-Young International Inc. Sponsored ADR (SY) trades at a EV/Sales of 0.4×. Over the past ten years it has ranged from −0.8× (November 2022) to 7.4× (July 2020); the current reading is higher than 57% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.6× | — |
| FY2024 | −0.4× | — |
| FY2023 | −0.3× | — |
| FY2022 | −0.4× | — |
| FY2021 | 0.3× | (82.11%) |
| FY2020 | 1.5× | (54.80%) |
| FY2019 | 3.3× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.2× | (77.07%) |
| Mar 2026 | 0.7× | 14.87% |
| Dec 2025 | 0.6× | (55.18%) |
| Sep 2025 | 1.3× | 44.42% |
| 26 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AMWL American Well Corporation compare | 0.1× |
| DH Definitive Healthcare Corp. compare | 0.4× |
| SY So-Young International Inc. Sponsored ADR | 0.4× |
| LFMD LifeMD, Inc. compare | 0.5× |
| HCAT Health Catalyst, Inc. compare | 0.7× |
| CCLD CareCloud, Inc. compare | 1.0× |
| SPOK Spok Holdings, Inc. compare | 1.6× |
| OPRX OptimizeRx Corp. compare | 1.6× |
| CTEV Claritev Corporation compare | 5.0× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)